Pulmonary Artery Pressure as a Treatment Target to Improve the Prognosis of Idiopathic Pulmonary Arterial Hypertension ― Insight From a Cohort From Two Japanese Pulmonary Hypertension Centers ―
暂无分享,去创建一个
K. Fukuda | A. Goda | T. Satoh | M. Kataoka | Y. Tamura | K. Takeuchi | H. Kikuchi | T. Inami | M. Ishiguro
[1] M. Nishimura,et al. Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017). , 2019, Circulation journal : official journal of the Japanese Circulation Society.
[2] Z. Jing,et al. Risk stratification and medical therapy of pulmonary arterial hypertension , 2019, European Respiratory Journal.
[3] S. Miyata,et al. Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension , 2018, Heart and Vessels.
[4] M. Humbert,et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension , 2017, European Respiratory Journal.
[5] K. Fukuda,et al. Survival of Japanese Patients With Idiopathic/Heritable Pulmonary Arterial Hypertension. , 2017, The American journal of cardiology.
[6] A. Ogawa,et al. Rapid and high-dose titration of epoprostenol improves pulmonary hemodynamics and clinical outcomes in patients with idiopathic and heritable pulmonary arterial hypertension. , 2016, Journal of cardiology.
[7] Simon Gibbs,et al. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. , 2016, Revista espanola de cardiologia.
[8] A. Ogawa,et al. Long-term patient survival with idiopathic/heritable pulmonary arterial hypertension treated at a single center in Japan. , 2014, Life sciences.
[9] R. Benza,et al. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. , 2012, Chest.
[10] A. Ogawa,et al. Marked hemodynamic improvements by high-dose epoprostenol therapy in patients with idiopathic pulmonary arterial hypertension. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[11] M. Humbert,et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension , 2010, European Respiratory Journal.
[12] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[13] J. Hanley,et al. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.
[14] H. Miyata,et al. Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension. , 2017, Circulation journal : official journal of the Japanese Circulation Society.
[15] Keith McNeil,et al. International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). , 1998, American journal of respiratory and critical care medicine.